Wire Stories
Orum Therapeutics Announces Three Presentations at AACR 2023
BOSTON & DAEJEON, South Korea–(BUSINESS WIRE)–#ADC—Orum Therapeutics, Inc. (�Orum�), a private biotechnology company pioneering the development of tumor-directed targeted protein degraders (TPDs),...